NCT04635657 Cognitive Status After Removal of Skull Base Meningioma
| NCT ID | NCT04635657 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ohio State University |
| Condition | Meningioma |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2019-12-10 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2019-12-10 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this prospectively enrolling trial is to assess long-term cognitive outcomes of patients undergoing surgery for resection of a meningioma associated with the frontal and temporal lobes.
Eligibility Criteria
Inclusion Criteria: * Subject has a meningioma associated with the frontal or temporal lobes * Subject is scheduled to undergo open craniotomy or Endoscopic Endonasal surgery * Subject is 18 years of age or older * The subject must in the investigator's opinion, be psychosocially, mentally, and physically able to fully comply with this protocol including the required follow-up visits, the filling out of required forms, and have the ability to understand and give written informed consent * Previous surgery will not exclude the patient as a new baseline cognitive evaluation will occur. Exclusion Criteria: * Patient is a prisoner * Patient is 90 years of age or older * Pregnant women * Previous radiation to the brain
Contact & Investigator
Daniel Prevedello, MD
PRINCIPAL INVESTIGATOR
Ohio State University
Frequently Asked Questions
Who can join the NCT04635657 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 89 Years, studying Meningioma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04635657 currently recruiting?
Yes, NCT04635657 is actively recruiting participants. Contact the research team at Emma.Kurtz@osumc.edu for enrollment information.
Where is the NCT04635657 trial being conducted?
This trial is being conducted at Columbus, United States.
Who is sponsoring the NCT04635657 clinical trial?
NCT04635657 is sponsored by Ohio State University. The principal investigator is Daniel Prevedello, MD at Ohio State University. The trial plans to enroll 50 participants.